Sanofi’s Tiffany McLamarrah will be presenting “Capitalizing on the Power of Next Generation Gene Editing Using Cas-CLOVER” at 10:00 am on Conference Day 2. She will review use of the novel gene editing technique Cas-CLOVER to rapidly generate gene knock-out, using NGS and WGS to characterize gene knock-outs, and characterizing the stability of gene knock-outs over many generations.